Company / Working Capital per Share
Rein Therapeutics, Inc. Working Capital per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
-$0.09
FY2025
5-year range
-$0.09 / $4.08
FY2021-FY2025
Trend
-105.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has declined for 3 consecutive years, from $4.08 in FY2022 to $-0.09 in FY2025.
Based on SEC 10-K filings.
-0.09 in FY2025.
Declined from $3.06 to $-0.09 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Rein Therapeutics, Inc.'s working capital per share has declined for 3 consecutive years.
- In FY2025, working capital per share decreased 105.3% year-over-year.
- Peak working capital per share was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -9.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.09 | -105.3% |
| FY2024 | $1.62 | -47.0% |
| FY2023 | $3.06 | -25.1% |
| FY2022 | $4.08 | +309.5% |
| FY2021 | $1.00 | +124.2% |
| FY2020 | $0.44 | -52.2% |
| FY2019 | $0.93 | -16.6% |
| FY2018 | $1.11 | -99.0% |
| FY2017 | $108.57 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026